Prognostic role of serum soluble ST2 of advanced breast cancer patients: a retrospective cohort study

BACKGROUND: The soluble suppression of tumorigenicity 2 receptor (sST2) binds to interleukin-33 (IL-33) and blocks IL-33 and ST2 binding, suggesting that sST2 acts as a “decoy” receptor for IL-33 and is involved in the malignant progression of breast cancer. This paper aimed to investigate the diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chong, Li, Jianhua, Rossi, Lorenzo, Sun, Pei, She, Tiantian, He, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493791/
https://www.ncbi.nlm.nih.gov/pubmed/37701118
http://dx.doi.org/10.21037/tcr-23-792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493791/
https://www.ncbi.nlm.nih.gov/pubmed/37701118
http://dx.doi.org/10.21037/tcr-23-792

Ejemplares similares